Methyl-CpG-binding domain 3 inhibits stemness of pancreatic cancer cells via Hippo signaling-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Methyl-CpG-binding domain 3 inhibits stemness of pancreatic cancer cells via Hippo signaling

Published:2020-08 Issue:1 Volume:393 Page:112091
ISSN:0014-4827
Container-title:Experimental Cell Research
language:en
Short-container-title:Experimental Cell Research

Author:

Wang Huizhi,Feng Wen,Chen Wei,He Junbo,Min Jingyu,Liu Yawen,Li Feifan,Chen Jiaxi,Wu Shuhui,Chen Baoding,Gong Aihua,Xu Min

Funder

Natural Science Foundation of China

Natural Science Foundation of Jiangsu Provincal, China

Jiangsu key R & D program social development project, China

Graduate Research and Innovation Projects of Jiangsu Province

Publisher

Elsevier BV

Subject

Cell Biology

Reference29 articles.

1. Cancer statistics, 2019;Siegel;CA A Cancer J. Clin.,2019

2. Transcription factors as readers and effectors of DNA methylation;Zhu;Nat. Rev. Genet.,2016

3. A variant NuRD complex containing PWWP2A/B excludes MBD2/3 to regulate transcription at active genes;Zhang;Nat. Commun.,2018

4. c-Jun N-terminal phosphorylation antagonises recruitment of the Mbd3/NuRD repressor complex;Aguilera;Nature,2011

5. Reduced mRNA expression levels of MBD2 and MBD3 in gastric carcinogenesis;Pontes;Tumour Biol,2014

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Update on Gemcitabine-Based Chemosensitization Strategies in Pancreatic Ductal Adenocarcinoma;Frontiers in Bioscience-Landmark;2023-12-29

2. MBD3 as a Potential Biomarker for Colon Cancer: Implications for Epithelial-Mesenchymal Transition (EMT) Pathways;Cancers;2023-06-14

3. Pancreatic cancer stemness: dynamic status in malignant progression;Journal of Experimental & Clinical Cancer Research;2023-05-13

4. Craniofacial Development Is Fine-Tuned by Sox2;Genes;2023-01-31

5. The epigenetic regulation of cancer cell recovery from therapy exposure and its implications as a novel therapeutic strategy for preventing disease recurrence;Advances in Cancer Research;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3